GBA

BoardWare Announces 2023 Annual Results

Retrieved on: 
Tuesday, March 26, 2024
GBA, Government, Culture, BCI, Construction, Growth, Sport, Policy, Wheelchair, Artificial intelligence of things, Beihang University, Greater, COVID-19, Research, Accreditation, Software, Sale, App Store (iOS/iPadOS), AI, Web 3.0, Investment, Tourism, SME, Commerce, Zone, Artificial intelligence, Vendor

HONG KONG, Mar 26, 2024 - (ACN Newswire) - BoardWare Intelligence Technology Limited ("BoardWare" or together with its subsidiaries, the "Group"; stock code: 1204.HK), a leading company in the Greater Bay Area ("GBA") that offers comprehensive, high-quality and end-to-end enterprise IT solutions, today announced its annual results for the year ended 31 December 2023 ("2023" or the "Year").

Key Points: 
  • HONG KONG, Mar 26, 2024 - (ACN Newswire) - BoardWare Intelligence Technology Limited ("BoardWare" or together with its subsidiaries, the "Group"; stock code: 1204.HK), a leading company in the Greater Bay Area ("GBA") that offers comprehensive, high-quality and end-to-end enterprise IT solutions, today announced its annual results for the year ended 31 December 2023 ("2023" or the "Year").
  • The potential demands of various IT solutions resumed along with the end of the influence from COVID-19 pandemic.
  • With regard to business segments, the revenue from enterprise IT solutions increased 27.9% to HK$456.2 million.
  • Headquartered in Macao, BoardWare Intelligence Technology Limited is the leading company in the Macao IT solutions market.

CervoMed Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Updates

Retrieved on: 
Monday, April 1, 2024
Lewy body, Research, GBA, Administration, Plasma, Conference, MRI, DLB, GFAP, Basal forebrain, Patient, Journal, Chairperson, Sale, TID, Manuscript, Public expenditure, Biomarker, Glial fibrillary acidic protein, MD, University College London, Atrophy, Publication, Frontotemporal dementia, Alpha-synuclein, NIA, Research and development, Vertex Pharmaceuticals, Axonal transport, Dementia, CRVO

BOSTON, April 01, 2024 (GLOBE NEWSWIRE) -- CervoMed Inc. (NASDAQ: CRVO), a clinical stage company focused on developing treatments for age-related neurologic disorders, today reported its financial results for the fourth quarter and full year ended December 31, 2023.

Key Points: 
  • Moreover, the neflamapimod treatment effects on GFAP were correlated to clinical outcomes, assessed by the CDR-SB.
  • Cash Position: As of December 31, 2023, CervoMed had $7.8 million in cash and cash equivalents as compared to $4.1 million as of December 31, 2022.
  • This increase was attributed to the RewinD-LB Phase 2b clinical study in DLB which began in the first quarter of 2023.
  • Net Loss: Net Loss was $2.2 million for the year ended December 31, 2023, compared to a net loss of $5.8 million for year ended December 31, 2022.

AGBA Announces Fourth Quarter 2023 Earnings, Amid Challenging Macro Environment.

Retrieved on: 
Thursday, March 28, 2024
GBA, Growth, Platform, Form 10-K, Security (finance), Insurance, Chinese New Year, Film industry

HONG KONG, March 28, 2024 (GLOBE NEWSWIRE) -- NASDAQ-listed, AGBA Group Holding Limited (“AGBA” or “the Company”) the leading one-stop financial supermarket in Hong Kong released its financial results for the fourth quarter of 2023.

Key Points: 
  • HONG KONG, March 28, 2024 (GLOBE NEWSWIRE) -- NASDAQ-listed, AGBA Group Holding Limited (“AGBA” or “the Company”) the leading one-stop financial supermarket in Hong Kong released its financial results for the fourth quarter of 2023.
  • The Company generated $48.9 million in commissions from its Distribution Business during the fourth quarter of 2023, which is double the figure generated during the same period in 2022.
  • AGBA has thrived despite macroeconomic challenges, adapting its business model and positioning itself for continued growth.
  • For more details, please refer to the company’s report on Form 10-K filed with the Securities and Exchange Commission on 28 March 2024.

Aurora Mobile’s GPTBots Partners with PERAC Eduverse to Help Develop ChatGPT AI Course Series

Retrieved on: 
Thursday, March 14, 2024
GBA, JG, Personality, Learning, Prompt, Partnership, Knowledge, AI, Student, STEAM, City, ChatGPT, Creative, Marketing, Teaching, Tutoring

Aurora Mobile will use its AI bot creation platform, GPTBots, to help PERAC Eduverse develop the ChatGPT AI series of courses for primary and secondary school students in Hong Kong, further promoting the development of AI STEAM by cultivating students’ interest in AI.

Key Points: 
  • Aurora Mobile will use its AI bot creation platform, GPTBots, to help PERAC Eduverse develop the ChatGPT AI series of courses for primary and secondary school students in Hong Kong, further promoting the development of AI STEAM by cultivating students’ interest in AI.
  • In these scenarios, students can use AI chatbots to generate content, sounds, and images to express their creative ideas.
  • Students can create their own GPTBots on the GPTBots platform in about an hour without any programming experience.
  • This collaboration represents a significant effort to leverage AI technology for educational innovation, and both parties will continue to explore additional opportunities in the future.

Goranson Bain Ausley Expands Family Law Services to West Texas

Retrieved on: 
Wednesday, April 3, 2024
GBA, Growth, International Academy, Bar association, American Academy, Suite, Partnership

TEXAS, April 3, 2024 /PRNewswire-PRWeb/ -- Goranson Bain Ausley (GBA), the largest family law firm in Texas known for its dedication to protecting families and securing futures, is pleased to announce the opening of its newest office in Midland, Texas. This marks GBA's sixth office in the state and shows its commitment to growth, providing access to more family law resources throughout Texas.

Key Points: 
  • TEXAS, April 3, 2024 /PRNewswire-PRWeb/ -- Goranson Bain Ausley (GBA), the largest family law firm in Texas known for its dedication to protecting families and securing futures, is pleased to announce the opening of its newest office in Midland, Texas.
  • This marks GBA's sixth office in the state and shows its commitment to growth, providing access to more family law resources throughout Texas.
  • "I'm looking forward to building on a tradition of excellence and providing a new resource for clients needing comprehensive family law services in West Texas," said Cindy Tisdale, Partner.
  • Board Certified in Family Law by the Texas Board of Legal Specialization, Tisdale is the author of numerous articles and a frequent presenter at legal continuing education seminars.

Guangdong vows to take lead in contributing to China's economic growth: SCIO conference

Retrieved on: 
Sunday, March 31, 2024
GBA, Pearl River Delta, Industrialisation, Artificial intelligence, Wang, News, GDP

Wang Weizhong, governor of Guangdong Province, said at a news conference held by the State Council Information Office (SCIO) of China that Guangdong is committed to promoting high-quality development and leading China's modernization.

Key Points: 
  • Wang Weizhong, governor of Guangdong Province, said at a news conference held by the State Council Information Office (SCIO) of China that Guangdong is committed to promoting high-quality development and leading China's modernization.
  • Guangdong is a province with a large economy, a large population, and a large foreign trade.
  • According to Wang, Guangdong will make it a top priority to achieve its economic growth target in 2024.
  • The construction of the Guangdong-Hong Kong-Macao Greater Bay Area (GBA) is one of the priorities of the Guangdong government.

Guangdong vows to take lead in contributing to China's economic growth: SCIO conference

Retrieved on: 
Sunday, March 31, 2024
GBA, Pearl River Delta, Industrialisation, Artificial intelligence, Wang, News, GDP

Wang Weizhong, governor of Guangdong Province, said at a news conference held by the State Council Information Office (SCIO) of China that Guangdong is committed to promoting high-quality development and leading China's modernization.

Key Points: 
  • Wang Weizhong, governor of Guangdong Province, said at a news conference held by the State Council Information Office (SCIO) of China that Guangdong is committed to promoting high-quality development and leading China's modernization.
  • Guangdong is a province with a large economy, a large population, and a large foreign trade.
  • According to Wang, Guangdong will make it a top priority to achieve its economic growth target in 2024.
  • The construction of the Guangdong-Hong Kong-Macao Greater Bay Area (GBA) is one of the priorities of the Guangdong government.

Over 70 Hopeful Startups Primed for Hong Kong Mega Event of EPiC 2024 Grand Finale

Retrieved on: 
Wednesday, March 13, 2024
Schneider Electric, Property technology, Growth, Commercial, ICC, Hewlett Packard Enterprise, Corporation, BNP Paribas, Jebsen Group, Ecosystem, HKT, Investment, XR, CVF, Chinachem, Henderson Land Development, HKR International, Partnership, Digital, Ingram Micro, Fintech, Task force, UBS, Epic, GBA, Limited, Silicon, New World Development, Grand Finale, International Commerce Centre, HKX, Partner (business rank), Kowloon Motor Bus, HSBC, Management

This year, HKSTP has handpicked a star judging panel of leading figures from the Hong Kong innovation scene to determine the winners at EPiC 2024.

Key Points: 
  • This year, HKSTP has handpicked a star judging panel of leading figures from the Hong Kong innovation scene to determine the winners at EPiC 2024.
  • The current Grand Finale final judges include:
    Ar Donald Choi, JP, Executive Director & Chief Executive Officer, Chinachem Group;
    Jonathan Chiu, Hong Kong President, Schneider Electric (Hong Kong) Limited.
  • Photo 1: HKSTP successfully completed regional Elevator Pitch Competition 2024 (EPiC) Hong Kong Semi-final on 29 February 2024, with 12 of the Hong Kong's brightest innovators selected to participate in EPiC 2024 Grand Finale on 26 April 2024.
  • Photo 2: HKSTP successfully completed regional Elevator Pitch Competition 2024 (EPiC) Stuttgart Semi-final on 4-5 March 2024, with 20 of the European brightest innovators selected to participate in EPiC 2024 Grand Finale on 26 April 2024.

HKTDC's major focus areas promote Hong Kong's advantages

Retrieved on: 
Wednesday, February 21, 2024
Standard, HKTDC, GBA, Deluxe, Growth, Exhibition, Renewable energy, IRES, ESG, Multilateralism, Climate change, City, FHA, Council, Global Health, SME, I&T, Greentech, Public affairs, AFF, Communication, Tutoring

HONG KONG, Feb 21, 2024 - (ACN Newswire) - The Hong Kong Trade Development Council (HKTDC) today announced its major focus areas for 2024-2025, which strengthen Hong Kong's status as a leading global business and investment hub and convention and exhibition (C&E) centre.

Key Points: 
  • HONG KONG, Feb 21, 2024 - (ACN Newswire) - The Hong Kong Trade Development Council (HKTDC) today announced its major focus areas for 2024-2025, which strengthen Hong Kong's status as a leading global business and investment hub and convention and exhibition (C&E) centre.
  • The HKTDC is committed to promoting Hong Kong's advantages internationally and creating opportunities for Hong Kong businesses.
  • Looking ahead, we will further consolidate Hong Kong's status as an international financial, trade and international C&E centre and promote Hong Kong's strengths internationally.
  • - We will deepen collaboration with R&D and innovation centres of Hong Kong-based universities to promote technology commercialisation with a focus on healthtech.

CervoMed Announces Presentation of Biomarker Data from the AscenD-LB Phase 2a Trial and Preclinical Data Supporting Potential of Neflamapimod in Tau-Mediated Disease at AD/PD ™ 2024

Retrieved on: 
Tuesday, March 5, 2024
Axonal transport, Tauopathy, Neuron, CRVO, Cell biology, DLB, Plasma, Medical laboratory, MB, Phosphorylation, Overalls, FTD, GS, Vrije Universiteit Amsterdam, Publication, MAPK, Glial fibrillary acidic protein, GFAP, Axon, Brain, CNR, IW, EM, SDL, UCL, RAF kinase, Alpha-synuclein, Conference, Biomarker, AG, Lewy body, GBA, MD, Neurochemistry, PDF, JC, CP, Patient, Dementia, Basal forebrain, JA, Medical imaging

BOSTON, March 05, 2024 (GLOBE NEWSWIRE) -- CervoMed Inc. (NASDAQ: CRVO), a clinical stage company focused on developing treatments for degenerative diseases of the brain, today announced the presentation of biomarker data from the AscenD-LB Phase 2a trial of neflamapimod in patients with dementia with Lewy bodies (DLB), demonstrating that neflamapimod reduces plasma levels of glial fibrillary acidic protein (GFAP) compared placebo, and that the effects of neflamapimod on GFAP were inversely correlated to change in CDR-SB (reduction in GFAP associated with improvement in CDR-SB, and increase in GFAP associated with worsening in CDR-SB). These data will be featured in a poster presentation at the 18th International Conference on Alzheimer’s and Parkinson’s Diseases (AD/PD™) 2024, being held both virtually and in Lisbon, Portugal from March 5–9, 2024. In addition, academic researchers from UCL will be presenting data in a separate poster at the meeting demonstrating that p38MAPK inhibition, including with neflamapimod specifically, improves tau-induced axonal transport defects both in vitro and in a tauopathy mouse model.

Key Points: 
  • These data will be featured in a poster presentation at the 18th International Conference on Alzheimer’s and Parkinson’s Diseases (AD/PD™) 2024, being held both virtually and in Lisbon, Portugal from March 5–9, 2024.
  • “The effects on GFAP, particularly the association between GFAP response and clinical outcomes, further support that neflamapimod is clinically efficacious in patients with DLB,” said John Alam, MD, Chief Executive Officer of CervoMed.
  • A PDF copy of the GFAP poster presentation will be available on the “ Presentations and Publications ” section of the CervoMed website.
  • Title: NEW INSIGHTS IN THE DEVELOPMENT OF BIOMARKERS, IMAGING, AND THERAPY OF ALPHA-SYNUCLEIN, LRKK2, AND GBA PATHOLOGIES